Acute aseptic meningitis temporally associated with trimethoprim and sulfamethoxazole: Systematic review.

IF 3.1 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Gianmaria F Bernasconi, Gregorio P Milani, Elisabetta L T De Felice, Craig Laurence, Pietro B Faré, Benedetta Terziroli Beretta-Piccoli, Mario G Bianchetti, Sebastiano A G Lava
{"title":"Acute aseptic meningitis temporally associated with trimethoprim and sulfamethoxazole: Systematic review.","authors":"Gianmaria F Bernasconi, Gregorio P Milani, Elisabetta L T De Felice, Craig Laurence, Pietro B Faré, Benedetta Terziroli Beretta-Piccoli, Mario G Bianchetti, Sebastiano A G Lava","doi":"10.1111/bcp.16346","DOIUrl":null,"url":null,"abstract":"<p><p>Sulphonamides and trimethoprim, although generally well-tolerated, have been temporally associated with aseptic meningitis. To address its presentation and outcome, a literature search was performed. We retained articles reporting patients with features of acute aseptic meningitis following intake of trimethoprim, sulfamethoxazole or sulfisoxazole. A cerebrospinal fluid investigation in ≥1 episode was a prerequisite for inclusion. Sixty articles reporting on 74 patients experiencing a total of 155 episodes were retained. Forty-five (61%) patients had one or more recurrences. Median age at first episode was 43 (interquartile range [IQR] 23-61) years. Symptoms presented within 48 (IQR 6-168) hours of intake at the first episode and within 1.3 (IQR 1-5) hours at recurrences (p < .0001). Cerebrospinal fluid analysis revealed a predominantly neutrophilic (82%, IQR 65%-94%) pleocytosis (180, IQR 38-507 10<sup>6</sup> cells/L), without low glucose or high proteins. Recovery took place within 2 (IQR 1-3) days after stopping the suspected agent. All but one patient completely recovered.</p>","PeriodicalId":9251,"journal":{"name":"British journal of clinical pharmacology","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British journal of clinical pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/bcp.16346","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Sulphonamides and trimethoprim, although generally well-tolerated, have been temporally associated with aseptic meningitis. To address its presentation and outcome, a literature search was performed. We retained articles reporting patients with features of acute aseptic meningitis following intake of trimethoprim, sulfamethoxazole or sulfisoxazole. A cerebrospinal fluid investigation in ≥1 episode was a prerequisite for inclusion. Sixty articles reporting on 74 patients experiencing a total of 155 episodes were retained. Forty-five (61%) patients had one or more recurrences. Median age at first episode was 43 (interquartile range [IQR] 23-61) years. Symptoms presented within 48 (IQR 6-168) hours of intake at the first episode and within 1.3 (IQR 1-5) hours at recurrences (p < .0001). Cerebrospinal fluid analysis revealed a predominantly neutrophilic (82%, IQR 65%-94%) pleocytosis (180, IQR 38-507 106 cells/L), without low glucose or high proteins. Recovery took place within 2 (IQR 1-3) days after stopping the suspected agent. All but one patient completely recovered.

急性无菌性脑膜炎与三甲双胍和磺胺甲噁唑的时间相关性:系统回顾。
磺胺类药物和三甲氧苄氨嘧啶类药物虽然一般耐受性良好,但也曾与无菌性脑膜炎相关。针对其表现形式和结果,我们进行了文献检索。我们保留了报道患者在服用三甲氧苄啶、磺胺甲噁唑或磺胺异噁唑后出现急性无菌性脑膜炎特征的文章。纳入的前提条件是脑脊液检查≥1 次。共有 60 篇文章对 74 名患者的 155 次发病进行了报道。45例(61%)患者有一次或多次复发。首次发病的中位年龄为 43 岁(四分位数间距 [IQR] 23-61)。首次发病时,症状在摄入后 48(IQR 6-168)小时内出现,复发时症状在 1.3(IQR 1-5)小时内出现(p 6 cells/L),且无低血糖或高蛋白。停用可疑制剂后 2 天(IQR 1-3)内恢复。除一名患者外,其余患者均完全康复。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.30
自引率
8.80%
发文量
419
审稿时长
1 months
期刊介绍: Published on behalf of the British Pharmacological Society, the British Journal of Clinical Pharmacology features papers and reports on all aspects of drug action in humans: review articles, mini review articles, original papers, commentaries, editorials and letters. The Journal enjoys a wide readership, bridging the gap between the medical profession, clinical research and the pharmaceutical industry. It also publishes research on new methods, new drugs and new approaches to treatment. The Journal is recognised as one of the leading publications in its field. It is online only, publishes open access research through its OnlineOpen programme and is published monthly.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信